Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. qs mobile

QS Mobile

Setting a standard for personal digital sperm analysis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 QS Mobile project word cloud

Explore the words cloud of the QS Mobile project. It provides you a very rough idea of what is the project "QS Mobile" about.

labour    days    covers    feasibility    tests    privacy    manufacturing    swiss    mobile    treatments    infertility    commercialized    types    motility    children    b2c    comfort    precision    fertility    germany    globally    annual    cheaply    289    chances    time    undergoing    performing    secure    habits    consuming    semen    spermatozoa    that    classes    microfluidics    6m    serve    industry    2027    device    giving    takes    channels    reliability    b2b    clip    compact    lab    automated    biophos    men    image    visits    smartphones    manual    male    affordable    carry    don    conception    validated    home    installed    accurately    labs    sperm    automating    errors    total    afford    morphology    solution    hospitals    performed    qs    revenues    either    20    combines    disrupt    15    concentration    homes    inconvenient    video    market    intends    planning    217    qualisperm    optics    standardized    sales    quality    levels    exclusively    switzerland    removing    sme    proposition   

Project "QS Mobile" data sheet

The following table provides information about the project.

Coordinator		 BIOPHOS SA 

Organization address
address: PARC SCIENTIFIQUE EPFL PSE
city: LAUSANNE
postcode: 1015
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Switzerland [CH]
 Project website http://www.biophos.ch
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-10-01   to  2018-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIOPHOS SA CH (LAUSANNE) coordinator 50˙000.00

Map

 Project objective

QS Mobile is a novel clip-on device for smartphones for male sperm analysis. QS Mobile combines microfluidics technology, compact optics & advanced video image analysis to make sperm tests automated, removing the manual labour errors & providing precision & reliability levels comparable to labs. QS Mobile is the only solution that that covers all three types of sperm measurements required by WHO— concentration, different motility classes & spermatozoa morphology analysis. QS Mobile addresses the problem of time-consuming, inconvenient and not fully standardized tests of male infertility. Male infertility tests are currently performed exclusively in labs, and it takes several visits & several days to get a result. With QS Mobile male fertility tests can be carried out at home quickly, accurately & more cheaply than in the lab. It is targeted at men who are planning children, undergoing fertility treatments or interested to change their habits to increase their chances of conception. QS Mobile can also be used by hospitals that either don’t have or cannot afford a dedicated fertility lab. QS Mobile is developed by Biophos—a Swiss SME that commercialized QualiSperm—an industry-recognized advanced semen analysis technology installed in 15 labs in Germany & Switzerland & performing 20,000 sperm quality tests per year. With QS Mobile, Biophos intends to disrupt the market of male fertility tests by fully automating them and giving the affordable & reliable testing device to the men who need it, so that they can carry out the tests in privacy & comfort of their homes. By 2027 Biophos intends to serve 15-20% of total market with €217.2-289.6m annual revenues globally. In this phase 1 feasibility study Biophos will validated the B2C go-to-market approach & develop a value proposition for B2B market, develop sales & distribution channels & secure manufacturing partnerships.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "QS MOBILE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "QS MOBILE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

JUMPAIR (2018)

Decubitus Ulcers Diseases Diagnoses by means of Smart ICT Anti-Decubitus System based on known Ulcers Activity Biomarkers

Read More  

ClearRing (2018)

An innovative, minimally invasive medical device used for treatment of Benign Prostatic Hyperplasia symptoms.

Read More